FDA ammends recommendation for antidepressant blackbox warning

In a previous post, I reflected on unintended consequencesof the FDA blackbox warning on antidepressants.   The FDA has proposed modification of the warning that (a) extends the age range of the warning to 24 and (b) includes explicit recognition that there is no data indicating danger for other ages, and that untreated depression presents its own risk.   The American Psychiatric Association has issued this press release(note: .pdf file)  applauding this second part of the new FDA proposal.